A Randomized, double-blind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxin e for eradication of carbapenem-resistant klebsiella pneumoniae carriage

Infection Control and Hospital Epidemiology

Volumn 33, Issue 1, 2012, Pages 14-19

  Saidel Odes, Lisa ^a   Polachek, Hana ^a   Peled, Nehama ^a   Riesenberg, Klaris ^a   Schlaeffer, Francisc ^a   Trabelsi, Yafa ^a   Eskira, Seada ^a   Yousef, Baha ^a   Smolykov, Rozalia ^a   Codish, Shlomi ^a   Borer, Abraham ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; COLISTIN; COLISTIN PLUS GENTAMICIN; GENTAMICIN; UNCLASSIFIED DRUG;

AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM ISOLATE; CARBAPENEM RESISTANT KLEBSIELLA PNEUMONIAE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ERADICATION THERAPY; FEMALE; FOLLOW UP; GASTROINTESTINAL INFECTION; HUMAN; HUMAN TISSUE; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MALE; MICROBIOLOGICAL EXAMINATION; OROPHARYNGEAL INFECTION; PHASE 4 CLINICAL TRIAL; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; RECTAL CULTURE; SKIN CULTURE; THROAT CULTURE; URINE CULTURE;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CARBAPENEMS; CARRIER STATE; COLISTIN; DIGESTIVE SYSTEM; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; GENTAMICINS; GROIN; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; PHARYNX; RECTUM; URINE;

EID: 84055177500     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/663206     Document Type: Article

References (28)

1. Kochar S, Sheard T, Sharma R, et al. Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2009;30: 447-452.
2. Centers for Disease Control and Prevention (CDC). Guidance for control of infections with carbapenem-resistant or carbapenem-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep 2009;58:256-260.
3. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008;29:1099-1106.
4. Calfee D, Jenkins SG. Use of active surveillance cultures to detect asymptomatic colonization with carbapenem-resistant Klebsiella pneumoniae in intensive care unit patients. Infect Control Hosp Epidemiol 2008;29:966-968.
5. Borer A, Saidel-Odes L, Reisenberg K, et al. Attributable mortality of carbapenem resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol 2009;30:972-976.
6. Mouloudi E, Protonotariou E, Zagorianou A, et al. Bloodstream infections caused by metallo-b-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes. Infect Control Hosp Epidemiol 2010;31:1250-1256.
7. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008;52:1028-1033.
8. Silvestri L, Kerr S, Gullo A. Prevention of infection using selective decontamination of the digestive tract. In: van Saene HKF, Silvestri L, de la Cal MA, eds. Infection Control in the Intensive Care Unit. 2nd ed. Milan: Springer, 2005:297-312.
9. D'Amico R, Pifferi S, Leonetti C, Torri V, Tinazzi A, Liberati A. Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. BMJ 1998;316:1275-1285.
10. Haas LEM, Schultz MJ. Selective decontamination of the digestive tract reduces pneumonia and mortality. Crit Care Res Pract 2010;2010:501031. Published October 7, 2010.
11. Ulrich C, Harinck-de Weerd JE, Bakker NC, Jacz K, Doornbos L, de Ridder VA. Selective decontamination of the digestive tract with norfloxacin in the prevention of ICU-acquired infections: a prospective randomized study. Intensive Care Med 1989;15: 424-431.
12. Rocha LA, Martin MJ, Pita S, et al. Prevention of nosocomial infections in critically ill patients by selective decontamination of the digestive tract: a randomized, double blind, placebo-controlled study. Intensive Care Med 1992;18:398-404.
13. Krueger WA, Lenhart FP, Neeser G, et al. Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, doubleblind, placebo-controlled clinical trial. Am J Respir Crit Care Med 2002;166:1029-1037.
14. Nathens AB, Marshall JC. Selective decontamination of the digestive tract in surgical patients: a systematic review of the evidence. Arch Surg 1999;134:170-176.
15. Oostdijk EA, de Smet AM, Kesecioglu J, et al. The role of intestinal colonization with gram-negative bacteria as a source for intensive care unit-acquired bacteremia. Crit Care Med 2011;39: 961-966.
16. de Jonge E, Schultz MJ, Spanjaard L, et al. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 2003;362:1011-1016.
17. de Smet AM, Kluytmans JA, Cooper BS, et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009;360:20-31.
18. Brun-Buisson C, Legrand P, Rauss A, et al. Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli: study of an outbreak in an intensive care unit. Ann Intern Med 1989;110:873-881.
19. Taylor ME, Oppenheim BA. Selective decontamination of the gastrointestinal tract as an infection control measure. J Hosp Infect 1991;17:271-278.
20. Hammond JM, Potgieter PD, Saunders GL, Forder AA. Doubleblind study of selective decontamination of the digestive tract in intensive care. Lancet 1992;340:5-9.
21. Hebert C, Robicsek A. Decolonization therapy in infection control. Curr Opin Infect Dis 2010;23:340-345.
22. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: 20th Informational Supplement. CLSI document. Wayne, PA: Clinical and Laboratory Standards Institute, 2010. M100-S20.
23. Anderson KF, Lonsway DR, Rasheed JK, et al. Evaluation of methods to identify the Klebsiella pneumoniae carbapenase in Enterobactereaceae. J Clin Microbiol 2007;45:2723-2725.
24. European Committee on Antimicrobial Susceptibility Testing. Clinical breakpoint tables v1.3, 2011. http://www.eucast.org/clinicalbreakpoints/. Published January 5, 2011.
25. Borer A, Gilad J, Porat N, et al. Impact of 4% chlorhexidine whole-body washing on multidrug-resistant Acinetobacter baumannii skin colonisation among patients in a medical intensive care unit. J Hosp Infect 2007;67:149-155.
26. Vernon MO, Hayden MK, Trick WE, Hayes RA, Blom DW, Weinstein RA. The effectiveness of source control to reduce the bioburden of vancomicin-resistant Enterococci. Arch Intern Med 2006;166:306-312.
27. Zuckerman T, Benyamini N, Sprecher H, et al. SCT in patients with carbapenem resistant Klebsiella pneumoniae: a single center experience with oral gentamicin for the eradication of carrier state. Bone Marrow Transplant 2011;46:1126-1130.
28. Reilly NJ, Nunn AJ, Pollock K. Selective decontamination of the digestive tract: the role of the pharmacist. In: van Saene HKF, Silvestri L, de la Cal MA, eds. Infection Control in the Intensive Care Unit. 2nd ed. Milan: Springer, 2005:575-592.